Opioid abuse is a common problem in the United States. It is estimated that 2.4 million people in this country use heroin at some time in their lives. Addiction to heroin has several long-term consequences, including molecular changes in the brain, hepatitis-risk taking behavior, HIV-risk taking behavior, and criminal behavior. Buprenorphine is a partial opioid agonist that has been commercially available since 1978 in sublingual form for outpatient treatment of opioid dependence. A transdermal patch is preferable to intramuscular or sublingual formulations for treatment of opioid dependence because it (a) increases patient compliance, (b) minimizes diversion of the buprenorphine for illicit use, (c) reduces the frequency of medical appointments, and (d) provides buprenorphine in a controlled manner, which minimizes fluctuations in blood concentration and limits withdrawal symptoms. However, conventional buprenorphine patches suffer from peak-and-trough variations in drug delivery. We hypothesize that two photon polymerization may be used to create fracture-resistant, biocompatible microneedle structures that can be used on a daily basis over several months for autonomous treatment of opioid addiction. An exploratory program is needed to assess the structural and functional properties of microneedle-based """"""""smart"""""""" patches created using two photon polymerization. The proposed research plan contains four overlapping phases. Phase I will involve chemical characterization of Ormocer(R) materials created using two photon polymerization. Phase II will involve biological and functional characterization of Ormocer(R) microneedles. Phase III will involve integrating microneedles with pumping devices in autonomous """"""""smart"""""""" patch devices. Phase IV will include a series of in vivo studies in mice to examine the predictive validity of the """"""""smart"""""""" patch. The Phase IV experiments will build upon ongoing experiments within the co-PI's laboratory, which are examining the antinociceptive effects of opioid agonists as well as the development of tolerance and dependence following chronic opioid administration. The PI and the co-PI have already started developing preliminary studies;we have found that our complementary skills and facilities have allowed this joint research effort to progress at a much faster rate than would otherwise be possible. The proof-of-concept in vivo data from this award will form the basis for comprehensive in vivo animal and clinical studies that will examine the safety and efficacy of Ormocer(R) microneedles in a clinical environment. For example, comparison of """"""""smart"""""""" patch against conventional patch, intramuscular injection, and other treatment modalities will be performed. We anticipate that an autonomous """"""""smart"""""""" patch device could contribute to an improved quality of life, including improved social functioning, reduced HIV-risk taking behavior, reduced criminality, improved physical health, and improved psychological status, for patients seeking treatment for drug abuse.

Public Health Relevance

In the proposed work, we will integrate microneedles with pumps in """"""""smart"""""""" patches that may be used to provide autonomous management of opioid dependency and verification of compliance in a private setting. We envision several important public health outcomes from the proposed work. The data from this award will form the basis for in vivo animal and clinical studies that will examine the safety and efficacy of microneedle- based """"""""smart"""""""" patches in a clinical environment. """"""""Smart"""""""" patches may be used for active monitoring and treatment of patients undergoing maintenance withdrawal therapy;""""""""phased"""""""" induction onto buprenorphine and other opioid addiction treatment agents;and management of pain resulting from cancer or other chronic conditions (e.g., neuropathic pain). Microneedles may also be integrated with multiple biosensors to provide autonomous blood sampling, analysis, calibration, and drug delivery for individualized treatment of patients with multiple chronic conditions (e.g., HIV positive status and opioid addiction). We anticipate that an autonomous """"""""smart"""""""" patch device could contribute to an improved quality of life, including improved social functioning, reduced HIV-risk taking behavior, reduced criminality, improved physical health, and improved psychological status, for individuals seeking drug abuse treatment.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21DA026980-02
Application #
7894979
Study Section
Special Emphasis Panel (ZDA1-MXS-M (02))
Program Officer
Park, Moo Kwang
Project Start
2009-08-01
Project End
2012-07-31
Budget Start
2010-08-01
Budget End
2012-07-31
Support Year
2
Fiscal Year
2010
Total Cost
$145,522
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Biomedical Engineering
Type
Schools of Medicine
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Gittard, Shaun D; Chen, Bo; Xu, Huadong et al. (2013) The Effects of Geometry on Skin Penetration and Failure of Polymer Microneedles. J Adhes Sci Technol 27:227-243
Miller, Philip R; Skoog, Shelby A; Edwards, Thayne L et al. (2012) Multiplexed microneedle-based biosensor array for characterization of metabolic acidosis. Talanta 88:739-42
Windmiller, Joshua Ray; Bandodkar, Amay Jairaj; Valdes-Ramirez, Gabriela et al. (2012) Electrochemical sensing based on printable temporary transfer tattoos. Chem Commun (Camb) 48:6794-6
Hyde, G Kevin; Stewart, S Michael; Scarel, Giovanna et al. (2011) Atomic layer deposition of titanium dioxide on cellulose acetate for enhanced hemostasis. Biotechnol J 6:213-23
Gittard, Shaun D; Miller, Philip R; Boehm, Ryan D et al. (2011) Multiphoton microscopy of transdermal quantum dot delivery using two photon polymerization-fabricated polymer microneedles. Faraday Discuss 149:171-85; discussion 227-45
Ovsianikov, A; Malinauskas, M; Schlie, S et al. (2011) Three-dimensional laser micro- and nano-structuring of acrylated poly(ethylene glycol) materials and evaluation of their cytoxicity for tissue engineering applications. Acta Biomater 7:967-74
Gittard, Shaun D; Narayan, Roger J (2010) Laser direct writing of micro- and nano-scale medical devices. Expert Rev Med Devices 7:343-56
Gittard, Shaun D; Ovsianikov, Aleksandr; Chichkov, Boris N et al. (2010) Two-photon polymerization of microneedles for transdermal drug delivery. Expert Opin Drug Deliv 7:513-33
Gittard, Shaun D; Ovsianikov, Aleksandr; Akar, Hasan et al. (2010) Two Photon Polymerization-Micromolding of Polyethylene Glycol-Gentamicin Sulfate Microneedles. Adv Eng Mater 12:B77-B82
Petrochenko, Peter; Narayan, Roger J (2010) Novel approaches to bone grafting: porosity, bone morphogenetic proteins, stem cells, and the periosteum. J Long Term Eff Med Implants 20:303-15

Showing the most recent 10 out of 11 publications